{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:14:50Z","timestamp":1740147290500,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Carcinoid heart disease is the cardiac manifestation of carcinoid syndrome. There is limited research on rhythm management in patients with carcinoid heart disease. The association of typical atrial flutter and carcinoid heart disease in particular is poorly described.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here we present a case of a 77-year-old German woman with carcinoid heart disease and recurrent typical atrial flutter complicating the postoperative course after tricuspid valve replacement and its successful long-term rhythm control by ablation therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>There is limited evidence on rhythm management in patients with the rare diagnosis of carcinoid heart disease. Typical atrial flutter repeatedly complicated the postoperative course of our patient with carcinoid heart disease and could finally be treated curatively by ablation. Radiofrequency ablation should be considered as a valuable therapeutic component in the challenging therapy of this disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03251-8","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:02:48Z","timestamp":1643760168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ablation of typical atrial flutter as therapeutic component in carcinoid heart disease: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Susann","family":"Groschke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Weinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Richardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"T\u00f6lg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Iden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1608-4152","authenticated-orcid":false,"given":"Martin","family":"Borlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"issue":"1","key":"3251_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000507847","volume":"146","author":"C Jin","year":"2021","unstructured":"Jin C, et\u00a0al. Carcinoid heart disease: pathophysiology, pathology, clinical manifestations, and management. Cardiology. 2021;146(1):65\u201373.","journal-title":"Cardiology"},{"issue":"8","key":"3251_CR2","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00059-019-04866-2","volume":"44","author":"KH Kuck","year":"2019","unstructured":"Kuck KH, Phan HL, Tilz RR. New ESC guidelines 2019 for the treatment of supraventricular tachycardia. Herz. 2019;44(8):701\u201311.","journal-title":"Herz"},{"key":"3251_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11154-020-09624-y","volume":"22","author":"K Oleinikov","year":"2021","unstructured":"Oleinikov K, et\u00a0al. Update in carcinoid heart disease\u2014the heart of the matter. Rev Endocr Metab Disord. 2021;22:553.","journal-title":"Rev Endocr Metab Disord"},{"issue":"34","key":"3251_CR4","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/eurheartj\/ehv070","volume":"36","author":"A Dashwood","year":"2015","unstructured":"Dashwood A, Rahman A, Pavicic M. Carcinoid heart disease. Eur Heart J. 2015;36(34):2326.","journal-title":"Eur Heart J"},{"issue":"5","key":"3251_CR5","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/0002-8703(54)90152-0","volume":"47","author":"A Thorson","year":"1954","unstructured":"Thorson A, et\u00a0al. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome. Am Heart J. 1954;47(5):795\u2013817.","journal-title":"Am Heart J"},{"issue":"1","key":"3251_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijcard.2014.02.037","volume":"173","author":"R Dobson","year":"2014","unstructured":"Dobson R, et\u00a0al. The clinical presentation and management of carcinoid heart disease. Int J Cardiol. 2014;173(1):29\u201332.","journal-title":"Int J Cardiol"},{"issue":"1","key":"3251_CR7","first-page":"002216","volume":"8","author":"PC Fragkou","year":"2021","unstructured":"Fragkou PC, et\u00a0al. Rare presentation of a metastatic pancreatic neuroendocrine neoplasm presenting with atrial flutter. Eur J Case Rep Intern Med. 2021;8(1):002216.","journal-title":"Eur J Case Rep Intern Med"},{"issue":"2","key":"3251_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00392-006-0463-y","volume":"96","author":"C Langer","year":"2007","unstructured":"Langer C, et\u00a0al. Atrial fibrillation in carcinoid heart disease: the role of serotonin. A review of the literature. Clin Res Cardiol. 2007;96(2):114\u20138.","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"3251_CR9","first-page":"971","volume":"116","author":"JA Kuczma","year":"2006","unstructured":"Kuczma JA, Grzywa M. Broncho-pulmonary carcinoid with the cardiac arrhythmia manifestation. Pol Arch Med Wewn. 2006;116(4):971\u20133.","journal-title":"Pol Arch Med Wewn"},{"key":"3251_CR10","first-page":"9142598","volume":"2016","author":"AB Rupp","year":"2016","unstructured":"Rupp AB, et\u00a0al. Carcinoid syndrome-induced ventricular tachycardia. Case Rep Cardiol. 2016;2016:9142598.","journal-title":"Case Rep Cardiol"},{"issue":"2","key":"3251_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jacep.2020.08.009","volume":"7","author":"SA Shabtaie","year":"2021","unstructured":"Shabtaie SA, et\u00a0al. Catheter ablation in patients with neuroendocrine (carcinoid) tumors and carcinoid heart disease: outcomes, peri-procedural complications, and management strategies. JACC Clin Electrophysiol. 2021;7(2):151\u201360.","journal-title":"JACC Clin Electrophysiol"},{"key":"3251_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s40119-021-00221-x","volume":"10","author":"L Iden","year":"2021","unstructured":"Iden L, et\u00a0al. Ablation therapy as management of typical atrial flutter in the early period after cardiac surgery. Cardiol Ther. 2021;10:569.","journal-title":"Cardiol Ther"},{"issue":"10","key":"3251_CR13","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","volume":"69","author":"J Davar","year":"2017","unstructured":"Davar J, et\u00a0al. Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement. J Am Coll Cardiol. 2017;69(10):1288\u2013304.","journal-title":"J Am Coll Cardiol"},{"key":"3251_CR14","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.2147\/DDDT.S84177","volume":"9","author":"EM Wolin","year":"2015","unstructured":"Wolin EM, et\u00a0al. Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues. Drug Des Dev Ther. 2015;9:5075\u201386.","journal-title":"Drug Des Dev Ther"},{"issue":"1","key":"3251_CR15","first-page":"e3986","volume":"11","author":"MH Maqsood","year":"2019","unstructured":"Maqsood MH, Tameez Ud Din A, Khan AH. Neuroendocrine tumor therapy with lutetium-177: a literature review. Cureus. 2019;11(1):e3986.","journal-title":"Cureus"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03251-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03251-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:02:53Z","timestamp":1643760173000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03251-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3251"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03251-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}